Kyosseva SV, McGinnis JF. Cerium oxide nanoparticles as promising ophthalmic therapeutics for the treatment of retinal diseases. World J Ophthalmol 2015; 5(1): 23-30 [DOI: 10.5318/wjo.v5.i1.23]
Corresponding Author of This Article
Svetlana V Kyosseva, PhD, Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205, United States. svkiosseva@uams.edu
Research Domain of This Article
Ophthalmology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/